Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant

Thrombosis Research

Volumn 135, Issue 1, 2015, Pages 46-49

  Pengo, Vittorio ^a   Testa, Sophie ^b   Martinelli, Ida ^c   Ghirarduzzi, Angelo ^d   Legnani, Cristina ^e   Gresele, Paolo ^f   Passamonti, Serena M ^c   Bison, Elisa ^a   Denas, Gentian ^a   Jose, Seena Padayattil ^a   Banzato, Alessandra ^a   Ruffatti, Amelia ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b District Hospital   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d S MARIA NUOVA HOSPITAL   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f University Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; LUPUS ANTICOAGULANT; ANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; THROMBOEMBOLISM; THROMBOSIS; VEIN THROMBOSIS; VERY ELDERLY; BLOOD; IMMUNOLOGY; MULTIVARIATE ANALYSIS; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES; ANTIBODIES, ANTICARDIOLIPIN; BETA 2-GLYCOPROTEIN I; FEMALE; HUMANS; INCIDENCE; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84922552998     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.10.013     Document Type: Article

References (30)

1. S. Miyakis, M.D. Lockshin, T. Atsumi, D.W. Branch, R.L. Brey, and R. Cervera International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 2006 295 306
2. M. Galli, D. Luciani, G. Bertolini, and T. Barbui Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin anti- bodies in the antiphospholipid syndrome: a systematic review of the literature Blood 101 2003 1827 1832
3. B. de Laat, R.H. Derksen, R.T. Urbanus, and P.G. de Groot IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis Blood 105 2005 1540 1545
4. E.M. Bevers, M. Galli, T. Barbui, P. Comfurius, and R.F.A. Zwaal Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin Thromb Haemost 66 1991 629 632
5. J.D. Oosting, R.H.W. Derksen, I.W.G. Bobbink, T.M. Hackeng, B.N. Bouma, and P.G. De Groot Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: An explanation for their pathogenic mechanism? Blood 81 1993 2618 2625
6. H. Takeya, T. Mori, E.C. Gabazza, K. Kuroda, H. Deguchi, and E. Matsuura Anti-b2-Glycoprotein I monoclonal antibodies with lupus anticoagulant activity enhance b2-Glycoprotein I binding to phospholipids J Clin Invest 99 1997 2260 2268
7. H.B. de Laat, R.H. Derksen, R.T. Urbanus, M. Roest, and P.G. de Groot Beta2-glycoproteinI-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome Blood 104 2004 3598 3602
8. V. Pengo, A. Ruffatti, C. Legnani, P. Gresele, D. Barcellona, and N. Erba Clinical course of high-risk patients diagnosed with antiphospholipid syndrome J Thromb Haemost 8 2010 237 242
9. V. Pengo, A. Ruffatti, C. Legnani, S. Testa, T. Fierro, and F. Marongiu Incidence of a first thromboembolic event in asymptomatic carriers of high risk antiphospholipid antibody profile: a multicenter prospective study Blood 118 2011 4714 4718
10. V. Pengo, A. Biasiolo, P. Gresele, F. Marongiu, N. Erba, and F. Veschi A comparison of lupus anticoagulant-positive patients with clinical picture of antiphos- pholipid syndrome and those without Arterioscler Thromb Vasc Biol 27 2007 e309 e310
11. P.G. de Groot, B. Lutters, R.H. Derksen, T. Lisman, J.C. Meijers, and F.R. Rosendaal Lupus anticoagulants and the risk of a first episode of deep venous thrombosis J Thromb Haemost 3 2005 1993 1997
12. V. Pengo, A. Biasiolo, P. Gresele, F. Marongiu, N. Erba, F. Veschi on behalf of Participating Centres of Italian Federation of Thrombosis Centres (FCSA) Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples J Thromb Haemost 5 2007 925 930
13. R.T. Urbanus, B. Siegerink, M. Roest, F.R. Rosendaal, P.G. de Groot, and A. Algra Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case- control study Lancet Neurol 8 2009 998 1005
14. V. Pengo, A. Tripodi, G. Reber, J.H. Rand, T.L. Ortel, M. Galli Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis Update of the guidelines for lupus anticoagulant detection J Thromb Haemost 7 2009 1737 1740
15. A. Tincani, F. Allegri, G. Balestrieri, G. Reber, M. Sanmarco, and P. Meroni Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies Thromb Res 114 2004 553 558
16. V. Pengo, A. Biasiolo, P. Rampazzo, and T. Brocco dRVVT is more sensitive than KCT or TTI for detecting Lupus Anticoagulant activity of anti-b2-Glycoprotein-I autoantibodies Thromb Haemost 81 1999 256 258
17. R.A.S. Roubey Immunology of the antiphospholipid antibody syndrome Arthritis Rheum 39 1996 1444 1454
18. V. Pengo, A. Biasiolo, C. Pegoraro, and S. Iliceto A two-step coagulation test to identify antib2-glycoprotein I lupus anticoagulants J Thromb Haemost 2 2004 702 707
19. M.J. Simmelink, R.H. Derksen, J. Arnout, and P.G. de Groot A simple method to discriminate between beta2-glycoprotein I- and prothrombin-dependent lupus anticoagulants J Thromb Haemost 1 2003 740 747
20. B. de Laat, R.H. Derksen, R.T. Urbanus, and P.G. de Groot IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2-glycoprotein I cause LAC and their presence correlates strongly with thrombosis Blood 105 2005 1540 1545
21. P.A. McNeeley, J.S. Dlott, R.A. Furie, R.M. Jack, T.L. Ortel, and D.A. Triplett β2-glycoprotein I-dependent Anticardiolipin Antibodies Preferentially Bind the Amino Terminal Domain of β2-glycoprotein I Thromb Haemost 86 2001 590 595
22. A. Banzato, N. Pozzi, R. Frasson, V. De Filippis, A. Ruffatti, and E. Bison Antibodies to domain I of β2Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS) Thromb Res 128 2011 583 586
23. V. Pengo, G. Balestrieri, A. Tincani, L. Spatola, A. Biasiolo, and T. Brocco Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids Thromb Haemost 77 1997 123 126
24. A. Ruffatti, T.D. Ross, M. Ciprian, M.T. Bertero, S. Sciascia, S. Scarpato Antiphospholipid Syndrome Study Group of the Italian Society of Rheumatology Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study Ann Rheum Dis 70 2011 1083 1086
25. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, E.J. Benjamin, J.D. Berry, and W.B. Borden Heart Disease and Stroke Statistics - 2011 Update. A Report From the American Heart Association Circulation 123 2011 e18 e209
26. C.C. Mok, S.S.K. Tang, C.H. To, and M. Petri Incidence and Risk Factors of Thromboembolism Systemic Lupus Erythematosus. A Comparison of Three Ethnic Groups Arthritis Rheum 52 2005 2774 2782
27. K. Lechner, I. Simonitsch, J. Haselböck, U. Jäger, and I. Pabinger Acquired immune-mediated thrombophilia in lymphoproliferative disorders Leuk Lymphoma 52 2011 1836 1843
28. R. Cervera, and R.A. Asherson Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics Immunobiology 210 2005 735 741
29. L. Arnaud, A. Mathian, A. Ruffatti, D. Erkan, M. Tektonidou, and R. Cervera Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis Autoimmun Rev 13 Mar 2014 281 291
30. V. Pengo, A. Ruffatti, T. Del Ross, M. Tonello, S. Cuffaro, and A. Hoxha Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile J Thromb Haemost 11 2013 1 5